n(6)-carboxymethyllysine has been researched along with arabinogalactan in 1 studies
| Studies (n(6)-carboxymethyllysine) | Trials (n(6)-carboxymethyllysine) | Recent Studies (post-2010) (n(6)-carboxymethyllysine) | Studies (arabinogalactan) | Trials (arabinogalactan) | Recent Studies (post-2010) (arabinogalactan) |
|---|---|---|---|---|---|
| 803 | 44 | 365 | 678 | 10 | 332 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, S; Wang, N; Wang, Y; Xu, P; Yao, W; Zhang, J; Zhang, Y | 1 |
1 other study(ies) available for n(6)-carboxymethyllysine and arabinogalactan
| Article | Year |
|---|---|
Structural elucidation and anti-diabetic osteoporotic activity of an arabinogalactan from Phellodendron chinense Schneid.
Topics: Animals; Bone Density Conservation Agents; Diabetes Mellitus, Experimental; Galactans; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Lysine; Male; Osteoporosis; Phellodendron; Rats, Wistar; Receptor for Advanced Glycation End Products | 2021 |